Clinical Trials Directory

Trials / Unknown

UnknownNCT04130815

Aerosol Particle Size and Breathing Pattern During Inhaled Furosemide

Effect of Aerosol Particle Size and Breathing Pattern of Inhalation on Relief of Experimentally Induced Air Hunger by Inhaled Furosemide

Status
Unknown
Phase
Phase 1
Study type
Interventional
Enrollment
20 (estimated)
Sponsor
Oxford Brookes University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

The study hypothesises that the variability in relief of air hunger with inhaled furosemide that is reported in previous studies can be explained by the breathing pattern adopted during the inhalation and the droplet size in the aerosol, both of which would influence the site of deposition of the aerosol in the lungs

Detailed description

Recent studies suggest that inhaling furosemide as a mist reduces air hunger in healthy volunteers in whom air hunger is induced experimentally in the lab. However, how much reduction varies among individuals. It is not known if the way the mist is breathed (slow/deep or fast/shallow) or the size of the droplets in the mist (large or small) can explain the variation in relief. Both of these factors can influence the site of deposition of the aerosol in the lungs In this study the relief of air hunger (induced by hypercapnia and constrained ventilation) will be compared when furosemide is inhaled quickly or slowly, and when the mist has large or small droplets. 20 healthy volunteers will be recruited. After a practice session, the 'air hunger' test will be performed before and after 4ml of a 10mg/ml solution of furosemide (40mg). This will be repeated on 4 separate test days using a different method of inhaling the furosemide on each day.

Conditions

Interventions

TypeNameDescription
DRUGInhaled furosemide4ml of 10mg/ml solution of furosemide nebulized with small and large droplet sizes and inhaled with different breathing patterns

Timeline

Start date
2019-10-14
Primary completion
2020-09-01
Completion
2020-09-01
First posted
2019-10-17
Last updated
2019-10-18

Locations

1 site across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT04130815. Inclusion in this directory is not an endorsement.